Value Proposition

Kidney Stone Prevention Program

 

Stone Rates Drop by 80% in Dr. Coe and Dr. Asplin's Clinic

 

The leading North American study of the cost benefit of testing and treating kidney stone formers features the University of Chicago Kidney Stone Clinic headed by Litholink founders Coe and Asplin.  The study, published in Kidney International in 1996, was based on 1,092 stone formers treated at the clinic and included all the patients for whom records were kept.

Below is a graph showing the change in stone rates before and after treatment.  Treatment caused an 83% reduction in the rate of stone formation.


The study estimated the savings in this population are in the range of $2,158 per patient in the first year, net of treatment and pharmacy costs.  

Parks JH, Coe FL, The Financial Effects of Kidney Stone Prevention. Kidney International. 1996 Nov;50(5):1706-12.

Practices using Litholink have reported results that confirm the efficacy and transferability of the techniques used by Drs Asplin and Coe.  See, for example, the following:

Lingeman, et al. Medical reduction of stone risk. J Urology. 1998;160:1629-1634.

Coe et al. Differences in urine volume and supersaturation. J Urology. 2001; 166:423-428

Mardis et. al. Outcome of metabolic evaluation. J Urology. 2004;171:85